KH
MCID: KPS002
MIFTS: 41

Kaposiform Hemangioendothelioma (KH) malady

Categories: Rare diseases, Cardiovascular diseases, Fetal diseases

Aliases & Classifications for Kaposiform Hemangioendothelioma

About this section
Sources:
31ICD10 via Orphanet, 40MESH via Orphanet, 48NIH Rare Diseases, 54Orphanet, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Kaposiform Hemangioendothelioma:

Name: Kaposiform Hemangioendothelioma 48 54 68
Congenital Cutaneous Multifocal Kaposiform Hemangioendothelioma 48
Kaposiform Hemangio-Endothelioma 48
 
Khe 48
Kh 48

Characteristics:

Orphanet epidemiological data:

54
kaposiform hemangioendothelioma:
Inheritance: Not applicable; Age of onset: All ages

Classifications:



External Ids:

Orphanet54 ORPHA2122
ICD10 via Orphanet31 D18.0
MESH via Orphanet40 C537007
UMLS via Orphanet69 C1367420

Summaries for Kaposiform Hemangioendothelioma

About this section
MalaCards based summary: Kaposiform Hemangioendothelioma, also known as congenital cutaneous multifocal kaposiform hemangioendothelioma, is related to angioma, tufted and hemangioma-thrombocytopenia syndrome. An important gene associated with Kaposiform Hemangioendothelioma is GNA14 (G Protein Subunit Alpha 14), and among its related pathways are VEGF binds to VEGFR leading to receptor dimerization and NF-kappaB Signaling. Affiliated tissues include skin, endothelial and tongue, and related mouse phenotypes are liver/biliary system and muscle.

Related Diseases for Kaposiform Hemangioendothelioma

About this section

Diseases related to Kaposiform Hemangioendothelioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 75)
idRelated DiseaseScoreTop Affiliating Genes
1angioma, tufted11.1
2hemangioma-thrombocytopenia syndrome11.1
3hemangioendothelioma10.9
4lysteria monocytoigeneses meningitis10.2FLT4, PROX1
5hypomelanosis of ito10.2FLT4, PROX1
6pilomyxoid astrocytoma10.2FLT4, PROX1
7oculodentodigital dysplasia10.2FLT4, PROX1
8chromosome 18 pericentric inversion10.2FLT4, PROX1
9acrofacial dysostosis, patagonia type10.2FLT4, PROX1
10gapo syndrome10.2FLT4, KDR
11eosinophilic pneumonia10.2FLT4, KDR
12intracranial hypotension10.2KDR, PROX1
13hemangioma10.1
14lymphangiomatosis10.1
15pustulosis palmaris et plantaris10.1KDR, PECAM1
16neuropathy with hearing impairment10.1KDR, PECAM1
17benign idiopathic neonatal seizures10.1KDR, PECAM1
18factitious disorder10.1FLT4, KDR
19benign familial neonatal epilepsy10.1FLT4, KDR, PROX1
20lymphoma, large-cell, immunoblastic10.1FLT4, KDR, PROX1
21mediastinitis10.1
22central cervical cord syndrome10.1FLT4, PROX1
23lymph node disease10.1FLT4, PECAM1
24vesiculobullous skin disease10.0FLT4, KDR, PECAM1
25colonic benign neoplasm10.0MTOR, VWF
26phencyclidine abuse10.0CD34, FLT4
27charcot-marie-tooth disease, axonal, type 2f10.0KDR, PECAM1
28ritscher-schinzel syndrome 110.0CD34, PECAM1
29endotheliitis10.0
30alcohol-induced mental disorder10.0CD34, KDR
31dermoid cyst10.0CD34, VWF
32intraneural perineurioma9.9CD34, VWF
33fragile x syndrome9.9
34ovarian brenner tumor9.9FLT4, KDR, MTOR
35mucoepidermoid esophageal carcinoma9.9CD34, VWF
36cycloplegia9.9CD34, FLT4, PROX1
37hemiplegic migraine9.9FLI1, FLT4, KDR, PECAM1
38saethre-chotzen syndrome9.9CD34, FLT4, KDR
39extranodal nasal nk/t cell lymphoma9.9FLI1, MTOR
40laryngomalacia9.8
41lymphedema9.8
42hereditary lymphedema9.8
43scoliosis9.8
44tonsillitis9.8
45sarcoma9.8
46pericardial effusion9.8
47lymphangioma9.8
48cervicitis9.8
49laryngitis9.8
50duodenal obstruction9.8

Graphical network of the top 20 diseases related to Kaposiform Hemangioendothelioma:



Diseases related to kaposiform hemangioendothelioma

Symptoms & Phenotypes for Kaposiform Hemangioendothelioma

About this section

MGI Mouse Phenotypes related to Kaposiform Hemangioendothelioma according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053709.1FLI1, FLT4, KDR, PECAM1, PROX1
2MP:00053697.9FLI1, FLT4, KDR, MTOR, PECAM1
3MP:00053857.8FLI1, FLT4, KDR, MTOR, PECAM1, PROX1
4MP:00053847.7CD34, FLI1, KDR, MTOR, PECAM1, PROX1
5MP:00053977.7CD34, FLI1, KDR, MTOR, PECAM1, PROX1
6MP:00053877.2CD34, FLI1, FLT4, KDR, MTOR, PECAM1

Drugs & Therapeutics for Kaposiform Hemangioendothelioma

About this section

Drugs for Kaposiform Hemangioendothelioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 15)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Miconazoleapproved, investigational, vet_approvedPhase 2370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
2
Sirolimusapproved, investigationalPhase 2194053123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
3
Vincristineapproved, investigationalPhase 29222068-78-2, 57-22-75978
Synonyms:
22-Oxovincaleukoblastin
22-Oxovincaleukoblastine
28379-27-3
57-22-7
AC1L1LJC
C07204
C46H56N4O10
CCRIS 5763
CHEBI:28445
CID5978
D08679
DB00541
EINECS 200-318-1
HMS2090E19
HSDB 3199
Indole alkaloid
LCR
LS-228
Leurocristine
Lilly 37231 (1:1 sulfate salt)
Liposomal Vincristine
Marqibo
NCGC00163700-01
NCI-C04864
NCI60_026703
NSC-67574
Onco TCS
 
Oncovin
Oncovin (1:1 sulfate salt)
Oncovine
Tecnocris
Tecnocris (TN)
UNII-5J49Q6B70F
VCR
VIN
Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine
Vincasar
Vincasar (1:1 sulfate salt)
Vincasar PFS
Vincrex
Vincrex (1:1 sulfate salt)
Vincristin
Vincristina
Vincristina [DCIT]
Vincristine (INN)
Vincristine Sulfate
Vincristine Sulfate PFS
Vincristine [INN:BAN]
Vincristinum
Vincristinum [INN-Latin]
Vincrstine
Vincrystine
Vinkristin
Z-D-Val-Lys(Z)-OH
vincristine
4
BenzocaineapprovedPhase 220161994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
5
EverolimusapprovedPhase 21940159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
6tannic acidapproved, NutraceuticalPhase 22016
7Antifungal AgentsPhase 23696
8Antibiotics, AntitubercularPhase 27180
9Antineoplastic Agents, PhytogenicPhase 25602
10Anti-Infective AgentsPhase 222062
11Immunosuppressive AgentsPhase 213086
12Antimitotic AgentsPhase 25657
13Anti-Bacterial AgentsPhase 211226
14Mitogens1617
15Endothelial Growth Factors382

Interventional clinical trials:

idNameStatusNCT IDPhase
1A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular TumorsRecruitingNCT02110069Phase 2
2Safety and Efficacy Study of Sirolimus in Complicated Vascular AnomaliesActive, not recruitingNCT00975819Phase 2
3Identification of Biomarkers for Patients With Vascular AnomaliesRecruitingNCT03001180
4Lymphatic Anomalies RegistryRecruitingNCT02399527

Search NIH Clinical Center for Kaposiform Hemangioendothelioma

Genetic Tests for Kaposiform Hemangioendothelioma

About this section

Anatomical Context for Kaposiform Hemangioendothelioma

About this section

MalaCards organs/tissues related to Kaposiform Hemangioendothelioma:

36
Skin, Endothelial, Tongue, Spleen, Cervix, Tonsil, Breast

Publications for Kaposiform Hemangioendothelioma

About this section

Articles related to Kaposiform Hemangioendothelioma:

(show top 50)    (show all 130)
idTitleAuthorsYear
1
Long-term outcome for kaposiform hemangioendothelioma: A report of two cases. (27701822)
2017
2
Imaging findings of Kaposiform Hemangioendothelioma in children. (28027747)
2017
3
Kaposiform Hemangioendothelioma in a 3A Months Old Infant. (27408442)
2016
4
Role of Sirolimus in Advanced Kaposiform Hemangioendothelioma. (26864138)
2016
5
Neonatal kaposiform hemangioendothelioma of the spleen associated with Kasabach-Merritt phenomenon. (27342010)
2016
6
Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon. (27981218)
2016
7
Bullous Kaposiform Hemangioendothelioma Masquerading as Aplasia Cutis Congenita. (27339319)
2016
8
Kaposiform Hemangioendothelioma: Multifocal Involvement, Chylothorax, and Kasabach-Merritt Phenomenon. (27820128)
2016
9
Treatment of kaposiform hemangioendothelioma and tufted angioma. (27252149)
2016
10
Recurrent multifocal cutaneous Kaposiform hemangioendothelioma: A rare vascular tumor of infancy and childhood. (27510687)
2016
11
Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol. (27100060)
2016
12
Abdominal Kaposiform Hemangioendothelioma Associated With Lymphangiomatosis Involving Mesentery and Ileum: A Case Report of MRI, CT, and 18F-FDG PET/CT Findings. (26871848)
2016
13
Interferon-alpha therapy for refractory kaposiform hemangioendothelioma: a single-center experience. (27796340)
2016
14
Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy. (26907642)
2016
15
An intermediate vascular tumour between kaposiform hemangioendothelioma and tufted angioma with regression of the skin lesion. (27882874)
2016
16
Multifocal Kaposiform Hemangioendothelioma Causing Massive Fetal Chylous Ascites. (27983885)
2016
17
Adult-onset Kaposiform hemangioendothelioma of the tongue: case report and review of the literature. (27803613)
2016
18
The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma. (27607323)
2016
19
Response to Paclitaxel in an Adult Patient with Advanced Kaposiform Hemangioendothelioma. (27721772)
2016
20
Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma. (27196448)
2016
21
Comment on: Steroid-resistant kaposiform hemangioendothelioma: A retrospective study of 37 patients treated with vincristine and long-term follow-up. (26052679)
2015
22
Refractory Kaposiform Hemangioendothelioma Associated with a Chromosomal Translocation t (13; 16) (q14; p13.3). (26555222)
2015
23
Kaposiform hemangioendothelioma: therapeutic efficacy for an enigmatic diagnosis. (25559734)
2015
24
Clinicopathological features of Kaposiform hemangioendothelioma. (26722599)
2015
25
Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms. (25662209)
2015
26
The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon. (25692091)
2015
27
A case of kaposiform hemangioendothelioma at the sigmoid colon. (26062947)
2015
28
Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in a neonate of life- and limb-threatening nature: A case report. (26628813)
2015
29
A rare case of kaposiform hemangioendothelioma presenting as intussusception in a 4-month-old child without Kasabach-Merrit syndrome: A case report. (25336808)
2014
30
Infantile hemangioma or kaposiform hemangioendothelioma? (24745913)
2014
31
Treating kaposiform hemangioendothelioma with kasabach-merritt phenomenon by intralesional injection of absolute ethanol. (25318440)
2014
32
Laryngomalacia and Complicated, Life-threatening mTOR-positive Kaposiform Hemangioendothelioma Cured by Supraglottoplasty and Sirolimus. (24810750)
2014
33
Successful treatment of kaposiform hemangioendothelioma with everolimus. (25306933)
2014
34
Pancreatic kaposiform hemangioendothelioma presenting with duodenal obstruction and kasabach-merritt phenomenon: a neonate cured by whipple operation. (25755958)
2014
35
CyberKnife Treatment for Kaposiform Hemangioendothelioma of the Ilium in an adult: case report and review of the literature. (25138302)
2014
36
Multifocal kaposiform hemangioendothelioma in multiple visceral organs: an autopsy of 9-day-old female baby. (24931465)
2014
37
Steroid-resistant kaposiform hemangioendothelioma: A retrospective study of 37 patients treated with vincristine and long-term follow-up. (25346262)
2014
38
Congenital fulminant Kaposiform hemangioendothelioma of the leg. (25277314)
2014
39
Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. (24482015)
2014
40
Multifocal kaposiform hemangioendothelioma of soft tissue with bilateral pulmonary involvement in an adolescent. (25550706)
2014
41
Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome mistaken for child abuse in a newborn. (24738105)
2014
42
Kaposiform hemangioendothelioma of paranasal sinus. (24619771)
2014
43
Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma. (24464150)
2014
44
Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. (22871490)
2013
45
Successful Treatment of Kasabach-Merritt Phenomenon Arising From Kaposiform Hemangioendothelioma by Sirolimus. (24309604)
2013
46
Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. (23796341)
2013
47
Microscopic Kaposiform hemangioendothelioma with extensive lymphangiomatosis: an extraordinary example of an unusual entity. (23129838)
2013
48
Paclitaxel-based chemotherapy for aggressive kaposiform hemangioendothelioma of the temporomastoid region: Case report and review of the literature. (22907922)
2013
49
Expansile kaposiform hemangioendothelioma deformed thoracic cage in an adult. (24182473)
2013
50
Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: ultrastructural observation and immunohistochemistry staining reveal the trapping of blood components. (24134598)
2013

Variations for Kaposiform Hemangioendothelioma

About this section

Expression for genes affiliated with Kaposiform Hemangioendothelioma

About this section
Search GEO for disease gene expression data for Kaposiform Hemangioendothelioma.

Pathways for genes affiliated with Kaposiform Hemangioendothelioma

About this section

GO Terms for genes affiliated with Kaposiform Hemangioendothelioma

About this section

Biological processes related to Kaposiform Hemangioendothelioma according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1lymph vessel developmentGO:000194510.3FLT4, PROX1
2lymphangiogenesisGO:000194610.3FLT4, PROX1
3cellular response to vascular endothelial growth factor stimulusGO:003592410.3FLT4, KDR
4endothelium developmentGO:000315810.2CD34, KDR
5hemostasisGO:000759910.1FLI1, VWF
6positive regulation of vasculogenesisGO:200121410.1CD34, KDR
7glomerular endothelium developmentGO:007201110.1CD34, PECAM1
8positive regulation of endothelial cell migrationGO:00105959.9FLT4, KDR, PROX1
9vascular endothelial growth factor signaling pathwayGO:00380849.6FLT4, KDR
10extracellular matrix organizationGO:00301989.6KDR, PECAM1, VWF
11positive regulation of protein phosphorylationGO:00019349.4FLT4, KDR, MTOR
12positive regulation of endothelial cell proliferationGO:00019389.1FLT4, KDR, MTOR, PROX1
13protein autophosphorylationGO:00467779.0FLT4, KDR, MTOR

Molecular functions related to Kaposiform Hemangioendothelioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1growth factor bindingGO:001983810.1FLT4, KDR
2transmembrane receptor protein tyrosine kinase activityGO:00047149.8FLT4, KDR
3vascular endothelial growth factor-activated receptor activityGO:00050219.6FLT4, KDR

Sources for Kaposiform Hemangioendothelioma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet